Samsung Pharmaceutical Co., Ltd. (KOSE:A001360) announced a private placement of 27th unregistered coupon unguaranteed private placement convertible bonds for gross proceeds of KRW 5,650,000,000 on October 24, 2016. The transaction included participation from 10 individual investors, including Taeho Kim for KRW 3,300,000,000, Wonseok Jung for KRW 500,000,000, and Hobum Song for KRW 500,000,000. The bonds are issued at par and will mature on October 24, 2019. The bonds carry yield to maturity of 4% and no annual coupon. The bonds can be fully converted into common shares of the company at a fixed conversion price of KRW 4,893 per share from October 24, 2017 to September 24, 2019. The transaction has been approved by the board of directors of the company.